Physiological monitor system for determining medication delivery and outcome

Abstract

A method is described for the determination of the taking of a medication utilizing at least one physiological parameter monitoring platform. In addition, the method also may enable the determination of physiological effects or events resultant from the taking of a medication (or lack thereof) through the use of one or more physiological monitoring platforms.

What is claimed is: 
     
         1 . A method for quantifying the effect of a medication on a patient, the method comprising:
 providing a monitoring platform capable of measuring one or more physiological parameters;   obtaining a first set of measurements of the physiological parameters from the patient by using the monitoring platform to measure the physiological parameters;   compiling a first signature from a first set of data including the first set of measurements; and   comparing the first signature with a second signature to determine the probability of a change in the physiological parameter.   
     
     
         2 . The method of  claim 1 , wherein the second signature is a baseline signature compiled from a second set of data including a second set of measurements of the physiological parameters obtained from the patient during a different period of time. 
     
     
         3 . The method of  claim 2 , wherein a non-physiological event has occurred between the first period of time and the second period of time. 
     
     
         4 . The method of  claim 3 , wherein the non-physiological event is a signal associated with removal of the medication from a container. 
     
     
         5 . The method of  claim 3 , wherein the non-physiological event is a signal associated with a delivery of the medication. 
     
     
         6 . The method of  claim 1 , wherein the second signature is a medication effect signature compiled from a second set of data including targeted endpoints for the physiological parameters. 
     
     
         7 . The method of  claim 1 , wherein the second signature is a predefined signature compiled from a second set of data including a second set of measurements of the physiological parameters obtained from one or more other patients. 
     
     
         8 . The method of  claim 1 , wherein the second signature is a side effect signature compiled from predefined tabular data for the physiological parameters. 
     
     
         9 . The method of  claim 1 , wherein the second signature is a composite representation of a signature compiled from a second set of data including a second set of measurements of the physiological parameters. 
     
     
         10 . The method of  claim 9 , wherein the composite representation is a multivariate representational line representative of the signature compiled from a second set of data including a second set of measurements of the physiological parameters. 
     
     
         11 . The method of  claim 1 , wherein the second signature is a signature associated with a degradation in health status. 
     
     
         12 . The method of  claim 1 , wherein compiling a first signature includes weighting each of the physiological parameters. 
     
     
         13 . The method of  claim 1 , wherein the first set of data further includes one or more of age, gender, and co-morbidities. 
     
     
         14 . The method of  claim 1 , wherein the obtaining a first set of measurements includes obtaining a first set of measurements for one or more periods of time having different lengths. 
     
     
         15 . The method of  claim 1 , wherein comparing the first signature with the second signature includes using a rolling analysis for a period of time. 
     
     
         16 . The method of  claim 1 , wherein comparing the first signature with the second signature includes determining a concordance between the first signature and the second signature. 
     
     
         17 . The method of  claim 1 , wherein comparing the first signature with the second signature includes using a cluster analysis. 
     
     
         18 . The method of  claim 1 , wherein comparing the first signature with the second signature includes using a trajectory analysis. 
     
     
         19 . The method of  claim 1 , wherein the medication is a therapy or an activity. 
     
     
         20 . The method of  claim 1 , wherein the medication is the avoidance of a behavior or an activity.